The combination of the novel glycolysis inhibitor 3-BrOP and rapamycin is effective against neuroblastoma

Por Levy, Alejandro G., Zage, Peter E., Akers, Lauren J., Ghisoli, Maurizio L., Chen, Zhao, Fang, Wendy, Kannan, Sankaranarayanan, Graham, Timothy, Zeng, Lizhi, Franklin, Anna R., Huang, Peng, Zweidler-McKay, Patrick A.
Publicado no Invest New Drugs (2010)